7Baggers
 How ONIT stock performs during market volatility  newser.com Fri, 03 Oct 2025 06:13:51 GMT
 Akari Therapeutics Completes August 2025 Notes Offering  MSN Wed, 01 Oct 2025 15:12:25 GMT
 akari therapeutics completes august 2025 notes offering  TipRanks Mon, 29 Sep 2025 21:35:26 GMT
 published on: 2025-09-29 11:18:27  newser.com Mon, 29 Sep 2025 16:18:27 GMT
 Akari Therapeutics Reveals Promising Preclinical Data for PH1  TipRanks Thu, 25 Sep 2025 21:33:59 GMT
 Akari reports data on ADC spliceosome modulating payload PH1  BioWorld MedTech Thu, 25 Sep 2025 13:00:00 GMT
 Akari Therapeutics’ Preclinical Data Demonstrates the  GlobeNewswire Wed, 24 Sep 2025 12:48:12 GMT
 published on: 2025-09-18 11:51:31  newser.com Thu, 18 Sep 2025 16:51:31 GMT
 akari therapeutics (aktx) to release earnings on thursday  Defense World Thu, 18 Sep 2025 05:13:31 GMT
 published on: 2025-09-17 18:54:55  newser.com Wed, 17 Sep 2025 23:54:55 GMT
 Akari Therapeutics files patent for novel cancer treatment approach  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 akari therapeutics enters share purchase agreement  MSN Tue, 16 Sep 2025 20:35:18 GMT
 published on: 2025-09-16 02:42:25  newser.com Tue, 16 Sep 2025 07:42:25 GMT
 published on: 2025-09-14 19:02:37  newser.com Mon, 15 Sep 2025 00:02:37 GMT
 published on: 2025-09-14 13:02:46  newser.com Sun, 14 Sep 2025 18:02:46 GMT
 published on: 2025-09-14 01:52:11  newser.com Sun, 14 Sep 2025 06:52:11 GMT
 published on: 2025-09-13 04:05:29  Newser Sat, 13 Sep 2025 09:05:29 GMT
 published on: 2025-09-12 01:11:57  Newser Fri, 12 Sep 2025 06:11:57 GMT
 published on: 2025-09-11 06:19:11  Newser Thu, 11 Sep 2025 11:19:11 GMT
 published on: 2025-09-10 23:39:09  Newser Thu, 11 Sep 2025 04:39:09 GMT
 akari therapeutics enters share purchase agreement  MSN Wed, 10 Sep 2025 13:58:14 GMT
 akari therapeutics (nasdaq:aktx) given buy rating at hc wainwright  Defense World Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-09 05:22:32  Newser Tue, 09 Sep 2025 10:22:32 GMT
 published on: 2025-09-09 02:08:10  Newser Tue, 09 Sep 2025 07:08:10 GMT
 Transcript : Akari Therapeutics, Plc - Special Call  MarketScreener Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 07:51:48  Newser Mon, 08 Sep 2025 12:51:48 GMT
 published on: 2025-09-08 04:57:21  Newser Mon, 08 Sep 2025 09:57:21 GMT
 published on: 2025-09-08 03:12:35  Newser Mon, 08 Sep 2025 08:12:35 GMT
 European Stocks In The US See Mixed Results This Week  Finimize Fri, 05 Sep 2025 06:53:54 GMT
 published on: 2025-09-05 00:36:04  Newser Fri, 05 Sep 2025 05:36:04 GMT
 european stocks in the us see mixed results this week  Finimize Thu, 04 Sep 2025 15:40:12 GMT
 published on: 2025-09-04 02:15:42  Newser Thu, 04 Sep 2025 07:15:42 GMT
 published on: 2025-09-03 03:51:21  Newser Wed, 03 Sep 2025 08:51:21 GMT

Akari Therapeutics, Plc
(NASDAQ:AKTX) 

AKTX stock logo

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases. Its lead product candidate is Coversin, a second-generation complement inhibitor that is in Phase I...

Full Time Employees: 10
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends